David Joseph Topper, Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 23,252 shares at $9.48 ($220K) on 2024-09-24, disclosed to the SEC on 2024-09-25.
Open-market sale of $220k ARQT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.48 | 11,626 | $110K | 50.0% |
| 2 | $9.48 | 11,626 | $110K | 50.0% |
| Total | $9.48 avg | 23,252 | $220K | 100% |